DKD HELIOS Klinik Wiesbaden GmbH

At DKD HELIOS Klinik Wiesbaden GmbH, clinical trials in cardiovascular disease and kidney disease focus on conditions such as chronic kidney disease and uncontrolled hypertension. These studies are designed to assess new treatment strategies that may help protect kidney function, reduce heart-related complications, and improve blood pressure control.

• Chronic kidney disease and combined kidney-heart outcome research
• Hypertension studies aimed at better blood pressure management
• Trials evaluating therapies to lower the risk of kidney failure, hospitalization for heart failure, and mortality

This area reflects a strong interest in improving long-term outcomes for patients living with complex cardiorenal conditions.

A major part of the research portfolio at this site centers on nervous system diseases, especially multiple sclerosis in its relapsing, progressive, and primary progressive forms. The trials are exploring ways to improve symptom control, slow disability progression, and better understand the patient experience of living with these conditions.

• Studies in relapsing multiple sclerosis and progressive multiple sclerosis
• Research on primary progressive multiple sclerosis and treatment effectiveness
• Trials assessing patient-reported impact and continued access to therapy

The site also contributes to research on broader neurological disease management, including efforts to maintain access to ongoing treatment for eligible participants.

Research in this therapeutic area includes studies on Parkinson's disease and lower limb spasticity, with a focus on easing motor symptoms and improving daily function. These trials are intended to test therapies that may reduce tremor, stiffness, and movement-related impairment.

• Parkinson's disease studies targeting residual tremor
• Trials for lower limb spasticity linked to neurological injury
• Work aimed at improving functional ability and symptom control

This research supports better care for patients whose neurological conditions affect mobility and everyday activities.

The site also participates in studies within immune system diseases, including generalized myasthenia gravis, as well as research on migraine. These trials are evaluating new ways to reduce disease burden, improve symptom relief, and support better day-to-day functioning.

• Generalized myasthenia gravis treatment research
• Migraine studies focused on acute symptom relief
• Trials testing therapies intended to improve quality of life and daily performance

Together, these studies show a broad interest in both chronic autoimmune conditions and common neurological pain disorders.